Robert P. Lenk, Director at PLUS THERAPEUTICS, INC. (PSTV), bought 6,000 shares at $1.43 ($9K) on 2023-11-13, disclosed to the SEC on 2023-11-15.
Open-market purchase of $9k PSTV by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.45 | 2,000 | $3K | 33.6% |
| 2 | $1.43 | 4,000 | $6K | 66.4% |
| Total | $1.44 avg | 6,000 | $9K | 100% |
| Filing → |
| PSTV | BUY | 2023-11-17 | $4K | — | Filing → |
| PSTV | BUY | 2023-11-13 | $15K | — | Filing → |
| PSTV | BUY | 2023-11-08 | $12K | — | Filing → |